ENTITY
Innovent Biologics Inc

Innovent Biologics Inc (1801 HK)

342
Analysis
Health CareChina
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
more
Refresh
Publication Icon
No publications yet
There aren’t any podcasts right now
Back to "All"
x